New Phase 1 Trial Results Capture Big But Misleading Headlines

November 29, 2015

A new set of Phase I study results published on November 25 has resulted in some very hopeful headlines about a possible cure. Unfortunately, the headlines are far more promising and hopeful than actual fact. Click here to read more. 

Flash Report:  JDRF New York City TypeOneNation Summit Highlights

November 6, 2015

This quick overview will first discuss the event in general and then will address in more detail information shared regarding both technological advances and research. Click here to read more.

Non-Profit Board of Directors Have The Power to Accelerate a T1D Cure

November 3, 2015

The board of directors at JDRF and the ADA ultimately have more influence over spending and strategy than anyone else at the organization. Board members set the organization’s strategic direction and have the final say in funding allocations. Click here to read more.

JDRF/JDCA Breakfast Meeting Flash Report

October 26, 2015

Last Friday the JDCA accepted an invitation to a breakfast meeting in New York with Derek Rapp, JDRF CEO, and John Brady, Chairman of the JDRF International Board, to discuss JDRF current and future priorities.  The conversation was straightforward and open. Click here to read more. 

Analyzing the ADA's Annual Income Utilization

October 15, 2015

This is the third annual analysis of the ADA's funding for research to help ensure that the  priorities of the T1D community are not lost in the ADA's heavy focus on type 2 diabetes. Click here to read more. 

2015 Fundraising Event Promise Report

October 8, 2015

This is the fourth annual review of the messages the ADA and JDRF use to raise money at national fundraising events. Click here to read more. 

Joslin's New Ceo Announced

October 5, 2015

Starting on October 5th, Dr. Peter Amenta will become the new Joslin President and CEO. Click here to read more about his background. 

Analyzing the JDRF's annual income utilization

September 22, 2015

This is the third annual analysis of JDRF's funding of research. The main purpose in reviewing and sharing this data is to help ensure that T1D donor and community priorities are being addressed.  Click here to read more. 

Flash Report: Joslin board asks CEO to resign without explanation

Sept 11, 2015

Joslin Diabetes Center released it's CEO of 4.5 years on Monday. Although details are limited and the news is still fresh, click here to read what we know so far. 

JDRF and Ada continue to decrease emphasis on cure RESEARCH

Sept 3, 2015

In a departure from our usual reports, this week we have an infographic to help discuss our latest findings. Click here to view it in full. 

Executive Compensation at TID Non-profits Still Not Linked to Cure Progress

August 26, 2015 

The JDCA's 4rth Annual Review of executive compensation is     here, and what we find isn't good. Click here to read more. 

The Bionic Pancreas: Further along FDA Testing Than Any Other AP

July 30, 2015 

Among the many artificial pancreas (AP) designs under development, the Bionic Pancreas project led by Dr. Ed Damiano of Boston University is progressing rapidly through human trials. Last week the JDCA had the opportunity to meet face-to-face with Dr. Damiano. Click here to read more. 

Islet Transplantation: A Brief Overview

July 14, 2015

This report provides a basic overview of the status of islet transplantation, one of the four Practical Cure pathways. The JDCA will publish an overview of                                                                      each of the other three Practical Cure pathways over the coming months.                                                                          Click here to read more.        

Update on Emerging Practical Cure Projects

June 24, 2015

A few weeks ago the JDCA published a report identifying research projects in human trials that may result in a Practical Cure. We also track Practical Cure projects which may begin human trials in the next 24 months. This report provides a list of those projects. Click here to read more.

Updates on Practical Cure Projects In Human Clinical Trials

June 10, 2016

This is the semi-annual review of T1D research in human clinical trials.  The review identified 361 open trials that focus on T1D and only 11 initiatives have the potential to deliver a Practical Cure. Click here to read more. 

Four Potential Research Pathways to a Practical Cure

May 28, 2015

This report is the first in a series of updates on developments in Practical Cure research platforms and projects. It outlines the four research pathways that we believe have the potential to deliver a Practical Cure within the next 15 years. Click here to read more. 

Edmonton Protocol Leader Publishes New Research that May Improve Islet Transplantation

May 7, 2015

The Journal of Nature Biology recently published results that appear to be a small step forward in islet transplantation. Click here to read more. 

New Clinical Trial Repurposes Rheumatoid Arthritus Drug for T1D

April 16, 2015

Last week Bloomberg News reported on a Phase II clinical trial that is testing whether an FDA-approved rheumatoid arthritis drug can be re-purposed to delay or halt the onset of type 1 diabetes. Click here to read more. 

JDRF Cost of Administering Research Grants Doubles in 5 Years

April 1, 2015

JDRF is becoming less efficient at administering research grants. In 2014, it cost JDRF 22 cents to administer each grant dollar of research, the highest level of any year in the past decade. Click here to read more.

New Study: T1D Treatments a 7 Billion Rapidly Growing Global Business 

March 26, 2015

A new study released by GlobalData, a London-based market research and analytics firm, estimates that the global market for type 1 diabetes treatments will double in the next decade, from $6.6 Billion in 2013 to $13.6 Billion by 2023. Click here to read more. 

Semma Therapeutics Raises $44 Million to Commercialize T1D Stem-Cell Research from Doug Melton’s Harvard Lab 

March 25, 2015

Today, in an article entitled “Biotech startup to fight diabetes on the cellular front,” The Boston Globe announced that a new company has been founded to commercialize T1D research out of Dr. Doug Melton’s laboratory at Harvard University. Click here to read more. 

Cure Research remains number 1 Priority in T1D Community

March 5, 2015

This is the JDCA's third annual survey-based report on the attitudes and desires of the type 1 diabetes community. Click here to read more

JDRF Shifts millions of dollars from research to education

February 10, 2015

There has been a steady decline in JDRF research funding over the last several years, while spending on all other parts of the budget has increased. Click here for a closer look at where the research grant money has gone.